Hofseth BioCare Balance Sheet Health
Financial Health criteria checks 2/6
Hofseth BioCare has a total shareholder equity of NOK112.7M and total debt of NOK101.0M, which brings its debt-to-equity ratio to 89.7%. Its total assets and total liabilities are NOK391.3M and NOK278.6M respectively.
Key information
89.7%
Debt to equity ratio
NOK 101.03m
Debt
| Interest coverage ratio | n/a |
| Cash | NOK 22.85m |
| Equity | NOK 112.65m |
| Total liabilities | NOK 278.62m |
| Total assets | NOK 391.27m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: HBCO's short term assets (NOK158.5M) do not cover its short term liabilities (NOK189.7M).
Long Term Liabilities: HBCO's short term assets (NOK158.5M) exceed its long term liabilities (NOK88.9M).
Debt to Equity History and Analysis
Debt Level: HBCO's net debt to equity ratio (69.4%) is considered high.
Reducing Debt: HBCO's debt to equity ratio has reduced from 442.7% to 89.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: HBCO has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: HBCO has less than a year of cash runway if free cash flow continues to reduce at historical rates of 12.4% each year